John Heasman
Chief Operating Officer at Epiminder | Sydney, New South Wales, Australia
John Heasman’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
John Heasman serves as Chief Operating Officer at Epiminder, a Sydney-based medical device company focused on advancing neurological care. He leads operational execution for the Minder® system, an implantable continuous EEG monitoring technology that has secured FDA de novo pathway authorization and is actively expanding its commercial presence in the United States. A University of Sydney graduate, he channels his background into scaling manufacturing, regulatory compliance, and market distribution for patients globally who do not respond to conventional epilepsy medications.
BEST APPROACH TO REACH John Heasman
Reach out via professional work email with a targeted message referencing Epiminder’s recent FDA de novo approval and propose a short discovery call to explore how your solutions can accelerate their Australian and US operational rollouts.
Chief Operating Officer at Epiminder in October 2020 - Present
Program Manager : Epi-Minder at Cochlear in June 2018 - October 2020
Senior Manager and Technology Leader at Cochlear in June 2014 - May 2018
Team Manager and Principal Engineer at Cochlear Ltd in January 2010 - June 2014
Principal Research Engineer at Cochlear in January 2008 - December 2009
Senior Research Engineer at Cochlear in January 2006 - December 2008
Reseach Engineer at Cochlear in December 2002 - December 2005
PhD - Biomedical Engineering at University of Sydney in January 1996 - December 2001
Biomedical Engineer at Spinal Cord Injuries Hand Research Group in December 1996 - June 2001
University of Sydney, Ph.D., November 1997 to November 2026
University of Sydney, B.Eng., November 1992 to November 1996
Epilepsy is a complex neurological condition affecting over 50 million people globally, with a significant part of the patient population not responding to traditional medication. Epilepsy not only imposes chronic, debilitating effects but also subjects patients to the unpredictable nature of when and how seizures might occur. Epiminder Limited is revolutionising epilepsy care with its implantable continuous EEG monitoring (iCEM®) system, the Minder® system. Minder has been granted authorization via the FDA's de novo pathway and is building a commercial presence in the US. Seizure diaries are often unreliable, the true picture of a patient's condition may be different from what it initially appears. This creates gaps in understanding of what treatments should be deployed to address the patient’s underlying condition. The Minder system will address this gap by unveiling continuous and objective EEG data that would not otherwise been seen. Like other diagnostic devices used in conditions requiring continuous monitoring of physiological signals (e.g. implantable cardiac monitors and continuous glucose monitors), the Minder system represents a significant leap forward in epilepsy care, providing objective insights that enable informed clinical actions. Headquartered in Melbourne, Australia, with an office in Dallas, TX, USA, Epiminder is a public company dedicated to advancing neurological health.
Discover more about Epiminder
Quality Assurance | Regulatory Affairs | Project Management
Quality Manager at Epiminder
(February 2024 – Present)
Chief Financial Officer
Chief Financial Officer at Healthscope
(Oct 2024 – Present)
Vice President of Market Access at Epiminder
My current role is to establish the US commercial organization to bring the first continuous, sub-scalp, EEG Monitoring system to the US market. I will be responsible for leading the early growth requirements that will include establishing the marketing, sales, and reimbursem...
Chief Executive Officer at Epiminder
President at Salient Medical
(Jan 2013 – Present)
VP, IT & Security at Epiminder
VP, IT & Security at Epiminder
(Jun 2024 – Present)
Chief Technology Officer at Epiminder
Recognising his specialised skillset, Toby has also established his own consulting company – MTASK Consulting, where he is available as a consultant in an ongoing or ad-hoc basis for companies looking for expertise in the following:
• Class III Active Implantables
• Med...
What is John Heasman email address?
Email John Heasman at [email protected] and [email protected]. This email is the most updated John Heasman's email found in 2026.
What is John Heasman phone number?
John Heasman phone number is +61421709938.
How to contact John Heasman?
To contact John Heasman send an email to [email protected] or [email protected]. If you want to call John Heasman try calling on +61421709938. (updated on December 09, 2025)
What company does John Heasman work for?
John Heasman works for Epiminder.
What is John Heasman's role at Epiminder?
John Heasman is Chief Operating Officer
What industry does John Heasman work in?
John Heasman works in the Medical Devices industry.
